Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Intercure Ltd.

CIK 1857030 INCR·Pharmaceutical Preparations · All EDGAR filings ↗

SEC comment letter Filing comparison

Intercure Ltd. responded to SEC staff comments on non-GAAP measures

Letter dated 2025-08-07; published on EDGAR 2026-01-16 — the SEC releases comment letters only after the review closes.

We note your use of Adjusted EBITDA, which represents EBITDA adjusted for changes in the fair value of inventory, share-based payment expense, impairment losses (and gains) on financial assets, and other expenses (or income). Please quantify the components of the adjustment for “other expenses, net” and explain your consideration of Item 10(e) of Regulation S-K in excluding these amounts from your Non-IFRS measure.…
Evidence
Direction
company to staff
Letter dated
2025-08-07
Published on edgar
2026-01-16
Reviewing
InterCure Ltd. (the “Company”) Form 20-F for the Fiscal Year Ended December 31, 2024 File No. 001-40614 Dear Mr. Wyman and Ms. Connell: We hereby provide the fo
Source
Company response to SEC staff (CORRESP)
Topics
Non-GAAP measures, Fair value, Inventory, Goodwill and impairment, MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.
SEC comment letter Filing comparison

SEC staff questioned Intercure Ltd.'s accounting for non-GAAP measures

Letter dated 2025-07-15; published on EDGAR 2026-01-16 — the SEC releases comment letters only after the review closes.

We note your use of Adjusted EBITDA, which represents EBITDA adjusted for changes in the fair value of inventory, share-based payment expense, impairment losses (and gains) on financial assets, and other expenses (or income). Please quantify the components of the adjustment for "other expenses, net" and explain your consideration of Item 10(e) of Regulation S-K in excluding these amounts from your Non-IFRS measure.…
Evidence
Direction
staff to company
Letter dated
2025-07-15
Published on edgar
2026-01-16
Reviewing
Intercure Ltd. Form 20-F for the Fiscal Year Ended December 31, 2024 Filed May 1, 2025 File No. 001-40614 Dear Amos Cohen: We have limited our review of your fi
Source
SEC staff comment letter (UPLOAD)
Topics
Non-GAAP measures, Fair value, Inventory, Goodwill and impairment, MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.